Kaufmann Gunnar F. 4
4 · Oncternal Therapeutics, Inc. · Filed Jan 24, 2022
Insider Transaction Report
Form 4
Kaufmann Gunnar F.
Chief Scientific Officer
Transactions
- Award
Stock Option
2022-01-20+162,457→ 162,457 totalExercise: $1.94Exp: 2032-01-20→ Common Stock (162,457 underlying)
Footnotes (1)
- [F1]One-fourth of the shares subject to the stock options shall vest on first anniversary of the date of grant, and the remaining shares subject to the option shall vest in 36 equal monthly installments over the three-year period thereafter, subject to the Reporting Person's continued employment or service with the Issuer on each such date.